María José Sanchez, Managing Director of CSL Behring , has been appointed as the new president of the Spanish Association of Orphan and Ultra Orphan Drug Laboratories (AELMHU), replacing Jorge Capapey, VP, Head of Commercial CEMEA at Alnylam, who will remain on the board as Vice President.

He will also be supported on the board by the vice-chairs: Leticia Beleta, General Manager of Alexion AstraZeneca Rare Disease in Spain, David Moreno, General Manager of PTC Therapeutics in Spain.